Report overview
Long acting drug delivery systems involve slow absorption of a drug containing active pharmaceutical ingredients, which are released into the system over subsequent time. The role of long acting drug delivery systems is clinically and medically beneficial for the treatment of chronic diseases and chronic pain, as well as certain neurological disorders. Long acting drug delivery systems include injectables, implants, microarrays or micro needle patches and broadly neutralizing monoclonal antibodies. The demand of long acting drug delivery systems is largely based on their high efficiency and targeted method of drug delivery.
This report contains market size and forecasts of Long Acting Drug Delivery in Global, including the following market information:
Global Long Acting Drug Delivery Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Long Acting Drug Delivery market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Device Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Long Acting Drug Delivery include ViiV Healthcare, Halozyme Therapeutics, Lubrizol Life Science, Celanese Corporation, Kashiv BioSciences, 4P Therapeutics, Ipsen, Midatech Pharma and Re-Vana Therapeutics and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Long Acting Drug Delivery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Long Acting Drug Delivery Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Long Acting Drug Delivery Market Segment Percentages, by Type, 2021 (%)
Device
Parenteral Injections
Global Long Acting Drug Delivery Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Long Acting Drug Delivery Market Segment Percentages, by Application, 2021 (%)
Hospital
Specialty Clinics
Clinical Research Institutes
Others
Global Long Acting Drug Delivery Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Long Acting Drug Delivery Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Long Acting Drug Delivery revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Long Acting Drug Delivery revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
ViiV Healthcare
Halozyme Therapeutics
Lubrizol Life Science
Celanese Corporation
Kashiv BioSciences
4P Therapeutics
Ipsen
Midatech Pharma
Re-Vana Therapeutics
Creative Biolabs
